Cargando…
Necrostatin-1 Alleviates Lung Ischemia-Reperfusion Injury via Inhibiting Necroptosis and Apoptosis of Lung Epithelial Cells
Lung ischemia-reperfusion injury (LIRI) is associated with many diseases, including primary graft dysfunction after lung transplantation, and has no specific and effective therapies. Necroptosis contributes to the pathogenesis of ischemia-reperfusion injury. Necrostatin-1 (Nec-1), the necroptosis in...
Autores principales: | Dong, Lingjun, Liang, Fuxiang, Lou, Zhiling, Li, Yangfan, Li, Jinsheng, Chen, Yaling, Ding, Jingjing, Jiang, Bin, Wu, Chuanqiang, Yu, Huan, Liu, Yafei, Zhang, Weiping, Lu, Yunbi, Wu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563441/ https://www.ncbi.nlm.nih.gov/pubmed/36231101 http://dx.doi.org/10.3390/cells11193139 |
Ejemplares similares
-
Necroptosis, necrostatins and tissue injury
por: Smith, Christopher CT, et al.
Publicado: (2011) -
Necrostatin-1 Synergizes the Pan Caspase Inhibitor to Attenuate Lung Injury Induced by Ischemia Reperfusion in Rats
por: Wang, Liangrong, et al.
Publicado: (2020) -
Necrostatin-1 and necroptosis inhibition: Pathophysiology and therapeutic implications
por: Cao, Liyuan, et al.
Publicado: (2021) -
Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis
por: Chen, Fuxiang, et al.
Publicado: (2017) -
Necrostatin-1 protects mice from acute lung injury by suppressing necroptosis and reactive oxygen species
por: Lin, Bi, et al.
Publicado: (2020)